Zobrazeno 1 - 10
of 957
pro vyhledávání: '"Risankizumab"'
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 11, Pp 3071-3081 (2024)
Abstract Introduction Despite advancements in the treatment of psoriasis (PsO), there are few head-to-head studies assessing comparative effectiveness of the newest therapies approved to treat PsO. Our objective was to assess the comparative clinical
Externí odkaz:
https://doaj.org/article/4674a01da9764f109764140e3aba0925
Autor:
Mohammed N. Al‐Abdulla, Wadha Al‐Shafi, Hanof Ahmed, Anh Jochebeth, Febu Joy, Shahd Younis, Mahir Petkar, Joerg Buddenkotte, Martin Steinhoff
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 4, Pp 1262-1266 (2024)
Abstract Pityriasis rubra pilaris (PRP) is a rare, chronic cutaneous inflammatory disorder of keratinization affecting adults, children and patients with HIV. The pathogenesis of PRP is not fully understood with clinical presentations, and severity r
Externí odkaz:
https://doaj.org/article/b6b89b1fff104e9687360456cdde1814
Autor:
Kenneth B. Gordon, Andrew Blauvelt, Hervé Bachelez, Laura C. Coates, Filip E. Van den Bosch, Blair Kaplan, Willem Koetse, Doug G. Ashley, Ralph Lippe, Ranjeeta Sinvhal, Kim A. Papp
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 9, Pp 2523-2538 (2024)
Abstract Introduction Risankizumab has demonstrated a favourable safety profile in patients with psoriatic disease (moderate-to-severe psoriasis [PsO] and psoriatic arthritis [PsA]). We evaluated the long-term safety of risankizumab in psoriatic dise
Externí odkaz:
https://doaj.org/article/83030d6abf4e47649d18fb5fdcb77867
Publikováno v:
JAAD Case Reports, Vol 48, Iss , Pp 108-111 (2024)
Externí odkaz:
https://doaj.org/article/e9fbbe9ed7fc4dd7b0b46e1952dc56cb
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Inflammatory bowel diseases (IBD), which enclose Crohn’s disease (CD) and ulcerative colitis (UC), are chronic, relapsing inflammatory ailments. Their specific pathogenesis is not completely clarified, the worldwide incidence and prevalence of IBD
Externí odkaz:
https://doaj.org/article/0eb9f488b5494d8daf17f660a9aea199
Autor:
Richard G. Langley, MD, Chiranjeev Sanyal, PhD, Aaron Situ, MSc, Sarah Alulis, MSc, Fareen Hassan, MSc, Steve Peterson, MPH, Rachel E. Teneralli, PhD, Jennifer Lee, MBA, Barkha P. Patel, PhD, Tim Disher, PhD
Publikováno v:
JAAD International, Vol 15, Iss , Pp 165-167 (2024)
Externí odkaz:
https://doaj.org/article/22186959faf64799ac3671ec41d4d380
Autor:
Shawn G. Kwatra, Saakshi Khattri, Ahmad Z. Amin, Roberto Ranza, Blair Kaplan, Linyu Shi, Byron Padilla, Ahmed M. Soliman, Dennis McGonagle
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 6, Pp 1517-1530 (2024)
Abstract Introduction The presence (vs absence) of enthesitis/dactylitis is associated with greater psoriatic arthritis (PsA) activity and reduced health-related quality of life. Risankizumab, an interleukin 23 antagonist, demonstrated superior treat
Externí odkaz:
https://doaj.org/article/208376fab02442ef8617f079f73a4f2b
Autor:
Andreas Pinter, Ahmed M. Soliman, Irina Pivneva, Roksana Ghanbariamin, Min Yang, Bang Truong, Luis Puig, Mark Lebwohl
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 5, Pp 1259-1271 (2024)
Abstract Introduction Real-world data on the efficacy of risankizumab (RZB) in clinical moderate-to-severe plaque psoriasis (PsO) are limited. The RAPID study assessed real-world clinical and patient-reported outcomes in RZB-treated PsO patients usin
Externí odkaz:
https://doaj.org/article/6166294923574c7eb1b770f5d1d6b0c3
Autor:
Lars Erik Kristensen, Mauro Keiserman, Kim Papp, Leslie McCasland, Douglas White, Kyle Carter, Ralph Lippe, Huzefa Photowala, Leonidas Drogaris, Ahmed M. Soliman, Michael Chen, Byron Padilla, Frank Behrens
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 3, Pp 617-632 (2024)
Abstract Introduction Patients with psoriatic arthritis (PsA) require treatment providing durable long-term efficacy in different disease domains as well as safety. We present 100-week efficacy and safety results of risankizumab in patients with acti
Externí odkaz:
https://doaj.org/article/d175f505a9724186801cfc38fbee94d1
Publikováno v:
JAAD International, Vol 16, Iss , Pp 57-58 (2024)
Externí odkaz:
https://doaj.org/article/c45aabfe3d904d97be1ac9f15632cb48